Massive CLL study tracks 2,000 patients to unlock best treatment order
NCT ID NCT06792994
First seen Jan 08, 2026 · Last updated May 18, 2026 · Updated 14 times
Summary
This study follows 2,000 people with chronic lymphocytic leukemia (CLL) to see how the order of treatments affects how long they live. It does not test new drugs but watches patients who already received standard first-line treatments in earlier studies. The goal is to find which treatment sequences lead to the best long-term survival.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC LYMPHOCYTIC LEUKEMIA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
University Hospital Cologne
RECRUITINGCologne, 50924, Germany
Contact Phone: •••-•••-•••• Email: •••••@•••••
-
Universitätsklinikum Ulm
RECRUITINGUlm, 89081, Germany
Conditions
Explore the condition pages connected to this study.